Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review 2024
Author: Research and Markets
Published At: 2024-12-26T09:33:00Z
Description:
Company Coverage includes Jazz Pharmaceuticals, UCB, Takeda Pharmaceutical, Biocodex, Longboard Pharmaceuticals, Stoke Therapeutics, Thermo Fisher Scientific, Harmony Biosciences Holdings, Ovid Therapeutics and Sage Therapeutics. Company Coverage includes Jaz…
Full Content:
Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's… [+4657 chars]
Related Keywords
news, latest updates, trending topics, global news
Insights
This article highlights recent developments in the world of news. Stay informed with the latest updates on global events, technology, politics, entertainment, and more. Dive into the details to get a comprehensive understanding of this topic.
Comments
Post a Comment